[EN] HETEROCYCLIC MOLECULES AS APOPTOSIS INDUCERS<br/>[FR] MOLÉCULES HÉTÉROCYCLIQUES EN TANT QU'INDUCTEURS D'APOPTOSE
申请人:BETA PHARMA CANADA INC
公开号:WO2013053045A1
公开(公告)日:2013-04-18
The present document describes novel compounds which may inhibit the activity of anti-apoptotic proteins such as Bcl-2 family protein members, compositions containing the compounds and methods of treating diseases involving a defect in apoptosis, such as, for example, in the treatment of cancer.
[EN] COMBINATION THERAPY FOR THE TREATMENT OF CANCER USING COX-2 INHIBITORS AND DUAL INHIBITORS OF EGFR [ERBB1] AND HER-2 [ERBB2]<br/>[FR] POLYTHÉRAPIE POUR LE TRAITEMENT DE CANCER AU MOYEN D'INHIBITEURS DE LA COX-2 ET D'INHIBITEURS DOUBLES DE L'EGFR [ERBB1] ET DE L'HER-2 [ERBB2]
申请人:TRAGARA PHARMACEUTICALS INC
公开号:WO2009042613A1
公开(公告)日:2009-04-02
Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
本文描述了一种用于治疗癌症、肿瘤和肿瘤相关疾病的组合物和使用这些组合物的方法。
2-AMINO PYRIMIDINE COMPOUNDS AS POTENT HSP-90 INHIBITORS
申请人:Kung Pei-Pei
公开号:US20100041681A1
公开(公告)日:2010-02-18
The present invention is directed to compounds of formula (I),
or pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors.
[EN] HETEROCYCLIC AMIDES COMPOUNDS WHICH ARE HDAC6 INHIBITORS AND USED AS ANTI-TUMORAL AGENTS<br/>[FR] COMPOSÉS DU TYPE AMIDES HÉTÉROCYCLIQUES INHIBITEURS DE LA HDAC 6 ET UTILISÉS COMME AGENTS ANTI-TUMORAUX
申请人:BETA PHARMA CANADA INC
公开号:WO2013078544A1
公开(公告)日:2013-06-06
The present document describes compounds of Formula I, pharmaceutical compositions comprising the same as well as methods of treating diseases such as a cancer, neurological disease, neurodegenerative disorder, stroke, traumatic brain injury, parasitic infection, inflammation or an autoimmune disease with said compounds.
This invention comprises novel compounds which inhibit the activity of anti-apoptotic Bcl-2 family protein members, compositions containing the compounds and methods of treating diseases involving a defect in apoptosis, such as, for example, in the treatment of cancer.